Alerts will be sent to your verified email
Verify Email
WANBURY
|
Wanbury
|
Bharat Parenterals
|
Anuh Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-30.56 % | 12.73 % | 15.87 % |
|
5yr Avg Net Profit Margin
|
7.58 % | 8.73 % | 7.23 % |
|
Price to Book
|
15.35 | 2.88 | 2.68 |
|
P/E
|
21.17 | 0.0 | 18.97 |
|
5yr Avg Cash Conversion Cycle
|
-119.82 Days | 122.06 Days | 42.81 Days |
|
5yr Average Interest Coverage Ratio
|
2.36 | 22.68 | 48.66 |
|
5yr Avg ROCE
|
-51.74 % | 16.02 % | 21.17 % |
|
5yr Avg Operating Profit Margin
|
4.22 % | 11.16 % | 10.21 % |
|
5 yr average Debt to Equity
|
-0.61 | 0.26 | 0.02 |
|
5yr CAGR Net Profit
|
-2.79 % | -9.67 % | 10.73 % |
|
5yr Average Return on Assets
|
11.1 % | 8.0 % | 9.84 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
39.63 % | 67.19 % | 69.92 % |
|
Share Pledged by Promoters
|
76.74 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.22 % | -6.65 % | -0.67 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Wanbury
|
Bharat Parenterals
|
Anuh Pharma
|
|---|